<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1561-6274-2009-13-4-28-36</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-1188</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ И ЛЕКЦИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS AND LECTURES</subject></subj-group></article-categories><title-group><article-title>ПОЧЕЧНЫЕ ГЕМОДИНАМИЧЕСКИЕ МЕХАНИЗМЫ ФОРМИРОВАНИЯ ГИПЕРТОНИЧЕСКОЙ НЕФРОПАТИИ</article-title><trans-title-group xml:lang="en"><trans-title>RENAL HEMODYNAMIC MECHANISMS DEVELOPMENT OF THE HYPERTENSIVE NEPHROPATHY</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кузьмин</surname><given-names>О. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuzmin</surname><given-names>O. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра фармакологии</p><p>460040, Оренбург, тел.: (3532) 77­ 49-66</p></bio><email xlink:type="simple">o.kuzmin.orgma@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бучнева</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Buchneva</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра фармакологии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пугаева</surname><given-names>М. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Pugaeva</surname><given-names>M. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра фармакологии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Оренбургская государственная медицинская академия</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>10</day><month>04</month><year>2009</year></pub-date><volume>13</volume><issue>4</issue><fpage>28</fpage><lpage>36</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кузьмин О.Б., Бучнева Н.В., Пугаева М.О., 2009</copyright-statement><copyright-year>2009</copyright-year><copyright-holder xml:lang="ru">Кузьмин О.Б., Бучнева Н.В., Пугаева М.О.</copyright-holder><copyright-holder xml:lang="en">Kuzmin O.B., Buchneva N.V., Pugaeva M.O.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/1188">https://journal.nephrolog.ru/jour/article/view/1188</self-uri><abstract><p>В обзоре рассматриваются современные представления о механизмах развития и прогрессирования гипертонической нефропатии, которая является одной из главных причин хронической болезни почек. Гипертоническая нефропатия является следствием нарушения работы почечных гемодинамических механизмов, защищающих клубочки от повреждающего действия повышенного артериального давления (АД). В результате в почках развиваются два принципиально разных патологических процесса – ишемическое и гипертрофическое повреждение клубочков, которые ведут к формированию фокально-сегментарного гломерулосклероза и нарастающей потере почечной функции. Причиной первого из них является избыточная ауторегуляторная реакция, осложняющаяся обструктивным гиалинозом афферентных артериол, ишемическим повреждением клубочков и потерей части функционирующих нефронов. Одновременно с ишемическим повреждением почек в сохранившихся нефронах развивается компенсаторный по своей природе феномен гиперфильтрации, ведущий к потере почечной ауторегуляции и стойкой гломерулярной гипертензии, которая становится главным фактором дальнейшего прогрессирования повреждения клубочков. В результате этих гемодинамических нарушений в почках развивается гипертрофический (пролиферативный) гломерулосклероз. Ключевую роль в его формировании играет гиперактивность клеточной РАС подоцитов, которая сопровождается избыточной продукцией TGF-β1 , VEGF и PDGF, вызывающих профибротическую структурно-функциональную перестройку подоцитов и мезангиальных клеток клубочков. Существенный вклад в этот патологический процесс вносит также прямое механическое повреждение подоцитов и мезангиальных клеток, способствующее их склеротическому перерождению и развитию воспалительной реакции в окружающей мезангиальной ткани.</p></abstract><trans-abstract xml:lang="en"><p>In the review are examined the contemporary concepts about the mechanisms of development and progression of hypertensive nephropathy, which is of the main reasons for the chronic kidney disease. Hypertensive nephropathy is the consequence of disruption of the work of renal hemodynamic mechanisms, which protect glomeruli from the damaging action increased arterial pressure. As a result in the kidneys are developed two principally different pathologic processes – ischemic and hypertrophic damage of the glomeruli, which lead to the formation of focal-segmental glomerulosclerosis and increasing loss of renal function. The reason for the first of them is the excessive autoregulatory reaction, which is complicated by obstructive hyalinosis of afferent arterioles, by the ischemic damage of glomeruli and by the loss of the part of functioning nephrons. Simultaneously the ischemic damage of the kidney in the preserved nephrons compensating by its nature phenomenon of hyperfiltration, which leads to the loss of renal autoregulation and steadfast glomerular hypertension, which becomes the major factor for future progression of the glomerular damage, is developed. As a result these hemodynamic disturbances in the kidney is developed hypertrophic (proliferating) glomerulosclerosis. The key role in its formation plays the hyperactivity of the cellular RAS of podocytes, which accompanied by the excess produce of TGF-β1 , VEGF and PDGF, causing profibrotic structural-functional reconstruction of podocytes and mesangial cells. The significant contribution to this pathologic process introduces also the direct mechanical damage of podocytes and mesangial cells, the facilities their sclerotic regeneration and development of inflammatory reaction in the surrounding mesangial tissue.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>гипертрофическая нефропатия</kwd><kwd>почечная ауторегуляция</kwd><kwd>гломерулярная гипертензия</kwd><kwd>клубочковая РАС</kwd><kwd>подоциты</kwd><kwd>мезангиальные клетки</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hypertensive nephropathy</kwd><kwd>renal autoregulation</kwd><kwd>glomerular hypertension</kwd><kwd>glomerular RAS</kwd><kwd>podocytes</kwd><kwd>mesangial cells</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Бикбов БТ, Томилина НА. Состояние заместительной терапии больных с хронической почечной недостаточностью в Российской Федерации в 1998–2005 гг. (Отчет по данным регистра Российского диализного общества). Нефрология и диализ 2007; 9 (1): 6-85</mixed-citation><mixed-citation xml:lang="en">Бикбов БТ, Томилина НА. Состояние заместительной терапии больных с хронической почечной недостаточностью в Российской Федерации в 1998–2005 гг. (Отчет по данным регистра Российского диализного общества). Нефрология и диализ 2007; 9 (1): 6-85</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Bidani AK, Griffin KA. Long-term renal consequences of hypertension for normal and diseased kidney. Curr Opin Nephrol Hypertens 2002; 11 (1): 73-80</mixed-citation><mixed-citation xml:lang="en">Bidani AK, Griffin KA. Long-term renal consequences of hypertension for normal and diseased kidney. Curr Opin Nephrol Hypertens 2002; 11 (1): 73-80</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Kriz W, Eberhard E, Nobiling R et al. A role podocytes to counteract capillary wall distension. Kidney Int 1994; 45 (2): 369-376</mixed-citation><mixed-citation xml:lang="en">Kriz W, Eberhard E, Nobiling R et al. A role podocytes to counteract capillary wall distension. Kidney Int 1994; 45 (2): 369-376</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Loutzenhiser R, Griffin K, Williamson G, Bidani A. Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanisms. Am J Physiol Regul 2006; 290 (5): R1153-R1167</mixed-citation><mixed-citation xml:lang="en">Loutzenhiser R, Griffin K, Williamson G, Bidani A. Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanisms. Am J Physiol Regul 2006; 290 (5): R1153-R1167</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Just A. Mechanisms of renal blood flow autoregulation: dynamics and contributions. Am J Physiol Regul 2007; 292 (1): R1-R17</mixed-citation><mixed-citation xml:lang="en">Just A. Mechanisms of renal blood flow autoregulation: dynamics and contributions. Am J Physiol Regul 2007; 292 (1): R1-R17</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Brannstrom K, Morsing P, Arendshort WJ. Exaggerated tubuloglomerular feedback activity in genetic hypertension is mediated by Ang II and AT1 receptor. Am J Physiol Renal 1996; 270 (5): F749-F755</mixed-citation><mixed-citation xml:lang="en">Brannstrom K, Morsing P, Arendshort WJ. Exaggerated tubuloglomerular feedback activity in genetic hypertension is mediated by Ang II and AT1 receptor. Am J Physiol Renal 1996; 270 (5): F749-F755</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Karlsen FM, Leyssac PP, Holstein-Rathlon NH. Tubuloglomerular feedback in Dahl rats. Am J Physiol Regul 1998; 274 (6): R1561-R1569</mixed-citation><mixed-citation xml:lang="en">Karlsen FM, Leyssac PP, Holstein-Rathlon NH. Tubuloglomerular feedback in Dahl rats. Am J Physiol Regul 1998; 274 (6): R1561-R1569</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Takabatake T, Ushioqi Y, Ohta K. Hattory N. Attenuation of enhanced tubuloglomerular feedback activity in SHR by renal denervation. Am J Physiol Renal 1990; 258 (4, Pt 2): F980-F985</mixed-citation><mixed-citation xml:lang="en">Takabatake T, Ushioqi Y, Ohta K. Hattory N. Attenuation of enhanced tubuloglomerular feedback activity in SHR by renal denervation. Am J Physiol Renal 1990; 258 (4, Pt 2): F980-F985</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Churg J, Sobin CH. Benign nephrosclerosis. In: Churg J ed. Renal disease – classification and atlas of glomerular diseases. Igaku-Shoin, Tokio, 1982; 211-224</mixed-citation><mixed-citation xml:lang="en">Churg J, Sobin CH. Benign nephrosclerosis. In: Churg J ed. Renal disease – classification and atlas of glomerular diseases. Igaku-Shoin, Tokio, 1982; 211-224</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Raij L. The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease. Am J Hypertens 2005; 18 [suppl 4s]: 95s-99s</mixed-citation><mixed-citation xml:lang="en">Raij L. The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease. Am J Hypertens 2005; 18 [suppl 4s]: 95s-99s</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Hills GS, Heudes D, Jacquot C et al. Morphometric evidence for impairment of renal autoregulation in advanced essential hypertension. Kidney Int 2006; 69 (5): 823-831</mixed-citation><mixed-citation xml:lang="en">Hills GS, Heudes D, Jacquot C et al. Morphometric evidence for impairment of renal autoregulation in advanced essential hypertension. Kidney Int 2006; 69 (5): 823-831</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Cortes P, Zhao X, Riser BL, Narins RG. Regulation of glomerular volume in normal and partially nephrectomized rats. Am J Physiol Renal 1996; 270 (2, Pt 2): F356-F370</mixed-citation><mixed-citation xml:lang="en">Cortes P, Zhao X, Riser BL, Narins RG. Regulation of glomerular volume in normal and partially nephrectomized rats. Am J Physiol Renal 1996; 270 (2, Pt 2): F356-F370</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Friedrich C, Endlich N, Kriz W, Endlich K. Podocytes are sensitive to fluid shear stress in vitro. Am J Physiol Renal 2006; 291 (4): F856-F865</mixed-citation><mixed-citation xml:lang="en">Friedrich C, Endlich N, Kriz W, Endlich K. Podocytes are sensitive to fluid shear stress in vitro. Am J Physiol Renal 2006; 291 (4): F856-F865</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Seikaky MG, Arant BS, Seney FD. Endogenous angiotensin concentrations in special intrarenal fluid compartments in the rat. J Clin Invest 1990; 86 (9): 1352-1357</mixed-citation><mixed-citation xml:lang="en">Seikaky MG, Arant BS, Seney FD. Endogenous angiotensin concentrations in special intrarenal fluid compartments in the rat. J Clin Invest 1990; 86 (9): 1352-1357</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Velez JCQ, Bland AM, Arthur J et al. Characterization of renin-angiotensin system enzyme activities in cultured podocytes. Am J Physiol Renal 2007; 293 (1): F398-F407</mixed-citation><mixed-citation xml:lang="en">Velez JCQ, Bland AM, Arthur J et al. Characterization of renin-angiotensin system enzyme activities in cultured podocytes. Am J Physiol Renal 2007; 293 (1): F398-F407</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Wang L, Flannery PJ, Spurney RF. Characterization of angiotensin II-receptor subtypes in podocytes. J Lab Clin Med 2003; 142 (5): 313-321</mixed-citation><mixed-citation xml:lang="en">Wang L, Flannery PJ, Spurney RF. Characterization of angiotensin II-receptor subtypes in podocytes. J Lab Clin Med 2003; 142 (5): 313-321</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Liebau MC, Lang D, Bohm J et al. Functional expression of the renin-angiotensin system in human podocytes. Am J Physiol Renal 2006; 290 (3): F710-F719</mixed-citation><mixed-citation xml:lang="en">Liebau MC, Lang D, Bohm J et al. Functional expression of the renin-angiotensin system in human podocytes. Am J Physiol Renal 2006; 290 (3): F710-F719</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Singh R, Singh AK, Alavi N, Leechy D. Mechanism of increased angiotensin II levels in glomerular mesangial cells cultured in high glucose. J Am Soc Nephrol 2003; 14 (4): 873-880</mixed-citation><mixed-citation xml:lang="en">Singh R, Singh AK, Alavi N, Leechy D. Mechanism of increased angiotensin II levels in glomerular mesangial cells cultured in high glucose. J Am Soc Nephrol 2003; 14 (4): 873-880</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Ardaillou R, Chansel D, Chatziantoniou C, Dussaule JC. Mesangial AT1 receptors: expression, signaling and regulation. J Am Soc Nephrol 1999; 10 [suppl 11]: S40-S46</mixed-citation><mixed-citation xml:lang="en">Ardaillou R, Chansel D, Chatziantoniou C, Dussaule JC. Mesangial AT1 receptors: expression, signaling and regulation. J Am Soc Nephrol 1999; 10 [suppl 11]: S40-S46</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Goto M, Mukoyama M, Sugawara A et al. Expression and role of angiotensin II type 2 receptor in the kidney and mesangial cells of spontaneously hypertensive rats. Hypertens Res 2002; 25 (1): 125-133</mixed-citation><mixed-citation xml:lang="en">Goto M, Mukoyama M, Sugawara A et al. Expression and role of angiotensin II type 2 receptor in the kidney and mesangial cells of spontaneously hypertensive rats. Hypertens Res 2002; 25 (1): 125-133</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Durvasula RV, Petermann AT, Hiromura K et al. Activation of local tissue angiotensin system in podocytes by mechanical strain. Kidney Int 2004; 65 (1): 30-39</mixed-citation><mixed-citation xml:lang="en">Durvasula RV, Petermann AT, Hiromura K et al. Activation of local tissue angiotensin system in podocytes by mechanical strain. Kidney Int 2004; 65 (1): 30-39</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Becker BN, Yasuda T, Kondo S et al. Mechanical stretch/relaxation stimulates a cellular renin-angiotensin system in cultured rat mesangial cells. Nephron Exp Nephrol 1998; 6 (1): 57-66</mixed-citation><mixed-citation xml:lang="en">Becker BN, Yasuda T, Kondo S et al. Mechanical stretch/relaxation stimulates a cellular renin-angiotensin system in cultured rat mesangial cells. Nephron Exp Nephrol 1998; 6 (1): 57-66</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Gruden J, Thomas S, Burt D et al. Interaction of angiotensin II and mechanical stretch on vascular endothelial growth factor production by human mesangial cells. J Am Soc Nephrol 1999; 10 (3): 730-737</mixed-citation><mixed-citation xml:lang="en">Gruden J, Thomas S, Burt D et al. Interaction of angiotensin II and mechanical stretch on vascular endothelial growth factor production by human mesangial cells. J Am Soc Nephrol 1999; 10 (3): 730-737</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Hoffman S, Podlich D, Hahnel B et al. Angiotensin II type I receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats. J Am Soc Nephrol 2004; 15 (6): 1475-1487</mixed-citation><mixed-citation xml:lang="en">Hoffman S, Podlich D, Hahnel B et al. Angiotensin II type I receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats. J Am Soc Nephrol 2004; 15 (6): 1475-1487</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Obata J, Nakamura T, Takano H et al. Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats. J Hypertens 2000; 18 (9): 1247-1255</mixed-citation><mixed-citation xml:lang="en">Obata J, Nakamura T, Takano H et al. Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats. J Hypertens 2000; 18 (9): 1247-1255</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Kang YS, Park YJ, Kim BK. Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes. J Mol Endocrinol 2006; 36 (2): 377-378</mixed-citation><mixed-citation xml:lang="en">Kang YS, Park YJ, Kim BK. Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes. J Mol Endocrinol 2006; 36 (2): 377-378</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Liy Y, Kang YS, Dai C et al. Epithelial-to-mesenchymal transition is a potential pathway to podocytes dysfunction and proteinuria. Am J Pathol 2008; 172 (2): 299-308</mixed-citation><mixed-citation xml:lang="en">Liy Y, Kang YS, Dai C et al. Epithelial-to-mesenchymal transition is a potential pathway to podocytes dysfunction and proteinuria. Am J Pathol 2008; 172 (2): 299-308</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Ding G, Reddy K, Kapasi AA et al. Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am J Physiol Renal 2002; 283 (1): F173-F180</mixed-citation><mixed-citation xml:lang="en">Ding G, Reddy K, Kapasi AA et al. Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am J Physiol Renal 2002; 283 (1): F173-F180</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Lai XX, Ding GH, Haang CX et al. Angiotensin II-induced podocytes apoptosis: a role of MAPK subtypes. Beijing Da Xue Bao 2004; 36 (2): 131-134</mixed-citation><mixed-citation xml:lang="en">Lai XX, Ding GH, Haang CX et al. Angiotensin II-induced podocytes apoptosis: a role of MAPK subtypes. Beijing Da Xue Bao 2004; 36 (2): 131-134</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Shu S, Liu Y, Wang L, Meng QH. Transforming growth factor-beta 1 is associated with kidney damage in patients with essential hypertension: renoproctive effect of ACE inhibitor and/or angiotensin II receptor blocker. Nephrol Dial Transplant 2008; 23 (9): 2841-2846</mixed-citation><mixed-citation xml:lang="en">Shu S, Liu Y, Wang L, Meng QH. Transforming growth factor-beta 1 is associated with kidney damage in patients with essential hypertension: renoproctive effect of ACE inhibitor and/or angiotensin II receptor blocker. Nephrol Dial Transplant 2008; 23 (9): 2841-2846</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Hirschberg R, Wang S, Mitu GM. Functional symbiosis between endothelium and epithelial cells in glomeruli. Cell Tissue Res 2008; 331 (2): 485-493</mixed-citation><mixed-citation xml:lang="en">Hirschberg R, Wang S, Mitu GM. Functional symbiosis between endothelium and epithelial cells in glomeruli. Cell Tissue Res 2008; 331 (2): 485-493</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Eremina V, Baedle HJ, Quaggin SE. Role of the VEGF-signaling pathway in the glomerulus: evidence for crosstalk between components of glomerular filtration barrier. Nephron Physiol 2007; 106 (2): 32-37</mixed-citation><mixed-citation xml:lang="en">Eremina V, Baedle HJ, Quaggin SE. Role of the VEGF-signaling pathway in the glomerulus: evidence for crosstalk between components of glomerular filtration barrier. Nephron Physiol 2007; 106 (2): 32-37</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Guan F, Villegas G, Teichman J et al. Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP. Am J Physiol Renal 2006; 291 (2): F422-F428</mixed-citation><mixed-citation xml:lang="en">Guan F, Villegas G, Teichman J et al. Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP. Am J Physiol Renal 2006; 291 (2): F422-F428</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Eremina V, Cui S, Gerber H et al. Vascular endothelial growth factor signaling in the podocytes-endothelial compartment is required for mesangial cell migration and survival. J Am Nephrol 2006; 17 (3): 724-735</mixed-citation><mixed-citation xml:lang="en">Eremina V, Cui S, Gerber H et al. Vascular endothelial growth factor signaling in the podocytes-endothelial compartment is required for mesangial cell migration and survival. J Am Nephrol 2006; 17 (3): 724-735</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Chen S, Lee JS, Iglesias-de la Cruz MC et al. Angiotensin II stimulates alpha3 (IV) collagen production in mouse podocytes via TGF-beta and VEGF signaling: implication for diabetic nephropathy. Nephrol Dial Transplant 2005; 20 (7): 1320-1328</mixed-citation><mixed-citation xml:lang="en">Chen S, Lee JS, Iglesias-de la Cruz MC et al. Angiotensin II stimulates alpha3 (IV) collagen production in mouse podocytes via TGF-beta and VEGF signaling: implication for diabetic nephropathy. Nephrol Dial Transplant 2005; 20 (7): 1320-1328</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Thomas S, Vanuystel J, Gruden G et al. Vascular endothelial growth factor receptors in human mesangium in vitro and in glomerular disease. J Am Soc Nephrol 2000; 11 (7): 1236-1243</mixed-citation><mixed-citation xml:lang="en">Thomas S, Vanuystel J, Gruden G et al. Vascular endothelial growth factor receptors in human mesangium in vitro and in glomerular disease. J Am Soc Nephrol 2000; 11 (7): 1236-1243</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Amamiya T, Sasamura H, Mifune M et al. Vascular endothelial growth factor activates MAP kinase and enhances collagen synthesis in human mesangial cells. Kidney Int 1999; 56 (6): 2055-2063</mixed-citation><mixed-citation xml:lang="en">Amamiya T, Sasamura H, Mifune M et al. Vascular endothelial growth factor activates MAP kinase and enhances collagen synthesis in human mesangial cells. Kidney Int 1999; 56 (6): 2055-2063</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Liu E, Marimoto M, Kitajima S et al. Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular function. J Am Soc Nephrol 2007; 18 (7): 2094-2104</mixed-citation><mixed-citation xml:lang="en">Liu E, Marimoto M, Kitajima S et al. Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular function. J Am Soc Nephrol 2007; 18 (7): 2094-2104</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Yamauchi T, Ogura T, Oishi T et al. The angiotensin 1-converting enzyme inhibitor cilazapril inhibits the platelet-derived growth factor B chain expression in glomeruli of spontaneously hypertensive rats. Ren Physiol Biochem 1995; 18 (5): 237-245</mixed-citation><mixed-citation xml:lang="en">Yamauchi T, Ogura T, Oishi T et al. The angiotensin 1-converting enzyme inhibitor cilazapril inhibits the platelet-derived growth factor B chain expression in glomeruli of spontaneously hypertensive rats. Ren Physiol Biochem 1995; 18 (5): 237-245</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Higueruelo S, Romero R. Angiotensin II requires PDGF-BB to induce DNA synthesis in rat mesangial cells cultured in exogenous insulin free medium. Nephrol Dial Transplant 1997; 12 (4): 694-700</mixed-citation><mixed-citation xml:lang="en">Higueruelo S, Romero R. Angiotensin II requires PDGF-BB to induce DNA synthesis in rat mesangial cells cultured in exogenous insulin free medium. Nephrol Dial Transplant 1997; 12 (4): 694-700</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Floege J, Eitner F, Alpers CE. A new look at platelet-derived growth factor in renal disease. J Am Soc Nephrol 2008; 19 (1): 12-23</mixed-citation><mixed-citation xml:lang="en">Floege J, Eitner F, Alpers CE. A new look at platelet-derived growth factor in renal disease. J Am Soc Nephrol 2008; 19 (1): 12-23</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Kretzler M. Regulation of adhesive interaction between podocytes and glomerular basement membrane. Microsc Res Tech 2002; 57 (4): 247-253</mixed-citation><mixed-citation xml:lang="en">Kretzler M. Regulation of adhesive interaction between podocytes and glomerular basement membrane. Microsc Res Tech 2002; 57 (4): 247-253</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Dai C, Stolz DB, Bastacky Si et al. Essential role of integrin-linked kinase in podocytes biology: bridging the integrin and slit diaphragm signaling. J Am Soc Nephrol 2006; 17 (8): 2164-2175</mixed-citation><mixed-citation xml:lang="en">Dai C, Stolz DB, Bastacky Si et al. Essential role of integrin-linked kinase in podocytes biology: bridging the integrin and slit diaphragm signaling. J Am Soc Nephrol 2006; 17 (8): 2164-2175</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Dessapt CBM, Hayward A, Viberti G, Gnudi L. TGF-β 1 and mechanical stretch reduce murine podocytes adhesion to extracellular matrix substrate and modulate β1 integrin expression/ maturation in vitro. Diabetologia 2005; [suppl 1]: A28 (abstract)</mixed-citation><mixed-citation xml:lang="en">Dessapt CBM, Hayward A, Viberti G, Gnudi L. TGF-β 1 and mechanical stretch reduce murine podocytes adhesion to extracellular matrix substrate and modulate β1 integrin expression/ maturation in vitro. Diabetologia 2005; [suppl 1]: A28 (abstract)</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Kanasaki K, Kanda Y, Palmsten K et al. Integrin beta1-mediated matrix assembly and signaling are critical for the normal development and function of kidney glomerulus. Dev Biol 2008; 313 (2): 584-593</mixed-citation><mixed-citation xml:lang="en">Kanasaki K, Kanda Y, Palmsten K et al. Integrin beta1-mediated matrix assembly and signaling are critical for the normal development and function of kidney glomerulus. Dev Biol 2008; 313 (2): 584-593</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Riser BL, Ladson-Wofford S, Sharba A et al. TGF-beta receptor expression and binding in rat mesangial cells: modulation by glucose and cyclic mechanical strain. Kidney Int 1999; 56 (2): 428-439</mixed-citation><mixed-citation xml:lang="en">Riser BL, Ladson-Wofford S, Sharba A et al. TGF-beta receptor expression and binding in rat mesangial cells: modulation by glucose and cyclic mechanical strain. Kidney Int 1999; 56 (2): 428-439</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Gruden G, Zonca S, Hayward A et al. Mechanical stretch-induced fibronectin and transforming growth factor-beta 1 production in human mesangial cells is p38 mitogen-activated protein kinase dependent. Diabetes 2000; 49 (4): 655-661</mixed-citation><mixed-citation xml:lang="en">Gruden G, Zonca S, Hayward A et al. Mechanical stretch-induced fibronectin and transforming growth factor-beta 1 production in human mesangial cells is p38 mitogen-activated protein kinase dependent. Diabetes 2000; 49 (4): 655-661</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Harris RC, Haralson MA, Badr KF. Continuous stretch-relaxation in culture alters rat mesangial cell morphology, growth characteristics and metabolic activity. Lab Invest 1992; 66 (3): 548-554</mixed-citation><mixed-citation xml:lang="en">Harris RC, Haralson MA, Badr KF. Continuous stretch-relaxation in culture alters rat mesangial cell morphology, growth characteristics and metabolic activity. Lab Invest 1992; 66 (3): 548-554</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Riser BL, Cortes P, Zhao X et al. Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat. J Clin Invest 1992; 90 (5): 1932-1943</mixed-citation><mixed-citation xml:lang="en">Riser BL, Cortes P, Zhao X et al. Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat. J Clin Invest 1992; 90 (5): 1932-1943</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Yasuda T, Kondo S, Homma T, Harris RC. Regulation of extracellular matrix by mechanical stress in rat glomerular mesangial cells. J Clin Invest 1996; 98 (9): 1991-2000</mixed-citation><mixed-citation xml:lang="en">Yasuda T, Kondo S, Homma T, Harris RC. Regulation of extracellular matrix by mechanical stress in rat glomerular mesangial cells. J Clin Invest 1996; 98 (9): 1991-2000</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Heilig CW, Concepcion LA, Riser BL et al. Overexpression of glucose transporters in rat mesangial cells cultured in normal glucose milieu mimics diabetic phenotype. J Clin Invest 1995; 96 (8): 1802-1814</mixed-citation><mixed-citation xml:lang="en">Heilig CW, Concepcion LA, Riser BL et al. Overexpression of glucose transporters in rat mesangial cells cultured in normal glucose milieu mimics diabetic phenotype. J Clin Invest 1995; 96 (8): 1802-1814</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Chen S, Heilig KO, Brosius FC, Heilig CW. Diabetes increases glomerular GLUT1 and antisense-GLUT1 protects against diabetic glomerulosclerosis (Abstract). J Am Soc Nephrol 2003; 14: 46A</mixed-citation><mixed-citation xml:lang="en">Chen S, Heilig KO, Brosius FC, Heilig CW. Diabetes increases glomerular GLUT1 and antisense-GLUT1 protects against diabetic glomerulosclerosis (Abstract). J Am Soc Nephrol 2003; 14: 46A</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Gnudi L, Viberti G, Raij L et al. GLUT-1 overexpression: link between hemodynamic and metabolic factors in glomerular injury? Hypertension 2003; 42 (1): 19-24</mixed-citation><mixed-citation xml:lang="en">Gnudi L, Viberti G, Raij L et al. GLUT-1 overexpression: link between hemodynamic and metabolic factors in glomerular injury? Hypertension 2003; 42 (1): 19-24</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Gnudi L, Viberti G. The link between mechanical stretch and glucose metabolism – a conceptual advance in understanding diabetic (and nondiabetic?) renal disease. Nephrol Dial Transplant 2007; 22 (2): 318-321</mixed-citation><mixed-citation xml:lang="en">Gnudi L, Viberti G. The link between mechanical stretch and glucose metabolism – a conceptual advance in understanding diabetic (and nondiabetic?) renal disease. Nephrol Dial Transplant 2007; 22 (2): 318-321</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Gruden G, Setti G, Hayward A et al. Mechanical stretch induces monocyte chemoattractant activity via an NF-kappa B-dependent monocyte chemoattractant protein-1-mediated pathway in human mesangial cells: inhibition by rosiglitazone. J Am Soc Nephrol 2005; 16 (3): 688-696</mixed-citation><mixed-citation xml:lang="en">Gruden G, Setti G, Hayward A et al. Mechanical stretch induces monocyte chemoattractant activity via an NF-kappa B-dependent monocyte chemoattractant protein-1-mediated pathway in human mesangial cells: inhibition by rosiglitazone. J Am Soc Nephrol 2005; 16 (3): 688-696</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Riser BL, Varani J, Cortes P et al. Cyclic stretching of mesangial cells up-regulated intercellular adhesion molecule-1 and leukocyte adherence: a possible new mechanism for glomerulosclerosis. Am J Pathol 2001; 158 (1): 11-17</mixed-citation><mixed-citation xml:lang="en">Riser BL, Varani J, Cortes P et al. Cyclic stretching of mesangial cells up-regulated intercellular adhesion molecule-1 and leukocyte adherence: a possible new mechanism for glomerulosclerosis. Am J Pathol 2001; 158 (1): 11-17</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Giunti S, Pinach S, Arnoldi L et al. The MCP/CCR2 system has direct proinflammatory effects in human mesangial cells. Kidney Int 2006; 69 (5): 856-863</mixed-citation><mixed-citation xml:lang="en">Giunti S, Pinach S, Arnoldi L et al. The MCP/CCR2 system has direct proinflammatory effects in human mesangial cells. Kidney Int 2006; 69 (5): 856-863</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Giunti S, Tesch GH, Pinach S et al. Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells. Diabetologia 2008; 51 (1): 198-207</mixed-citation><mixed-citation xml:lang="en">Giunti S, Tesch GH, Pinach S et al. Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells. Diabetologia 2008; 51 (1): 198-207</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Park J, Ryu S, Li JJ et al. MCP/CCR2 system is involved in high glucose-induced fibronectin and type IV collagen expression in cultured mesangial cells. Am J Physiol Renal 2008; 295 (3): F749-F757</mixed-citation><mixed-citation xml:lang="en">Park J, Ryu S, Li JJ et al. MCP/CCR2 system is involved in high glucose-induced fibronectin and type IV collagen expression in cultured mesangial cells. Am J Physiol Renal 2008; 295 (3): F749-F757</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
